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Bacterial lipopolysaccharides (LPS) enhance both production of colony-stim-
ulating factors (CSF) and proliferation of mononuclear phagocytes in vivo. The
present study was undertaken to determine whether the effects of LPS on CSF-
dependent monopoiesis are due solely to enhanced production of CSF or also to
direct effects of LPS on the responding progenitor cell. Addition of LPS to CSF-
stimulated macrophage populations had different effects, depending upon the
concentration of CSF in the cultures. In the presence of optimal to supraoptimal
concentrations of CSF, LPS at doses 20.01 jig/ml inhibited macrophage colony
formation. This inhibitory activity was not due to cytotoxicity of the LPS and
was not mediated through prostaglandin synthesis. In the presence of suboptimal
concentrations of CSF, minute concentrations of LPS (l0-7 tug/ml) significantly
enhanced macrophage colony formation. Both effects of LPS (inhibition and
enhancement) appeared to be properties of lipid A since neither effect was noted
with cells from LPS-resistant C3H/HeJ mice, whereas both effects could be
neutralized by the addition of the antibiotic polymyxin B, which binds to the
lipid A portion of LPS. These results suggest that the effects of LPS on mono-
poiesis in vivo may not be due solely to its capacity to stimulate production of
CSF. Rather, LPS may be involved in stimulating monopoiesis both indirectly
through stimulation of CSF production and by its effects on the CSF-responsive
progenitor cell.
Bacterial endotoxins and their lipopolysac-
charide (LPS) moieties act on a variety of mam-
malian cell types (reviewed in reference 3). Of
these cell types, monocytes and macrophages
are perhaps the most sensitive to the effects of
LPS. Teleologically, this is acceptable since
these cells are the most likely to encounter either
LPS or gram-negative bacteria in either endo-
toxemic or infected animals.
LPS has been shown to exert a variety of
seemingly direct effects on macrophages. In ex-
treme cases LPS can be cytotoxic for macro-
phages (14, 33, 37). In a majority of experimental
systems, however, LPS is stimulatory rather
than lethal. This stimulation has been detected
as enhancement of killing capacity (1, 10, 47)
and associated production ofoxygen metabolites
(32), secretion of proteolytic enzymes (3, 46),
and production of a variety of soluble mediators
(13, 23, 24, 26, 27, 43, 45), including colony-stim-
ulating factor (CSF; 12). CSF is a myeloprolifer-
ative agent (4, 5, 34) that has the capacity to
stimulate clonal proliferation and differentiation
of macrophage precursors (38, 39). Both LPS (6,
8, 21, 35) and infection with gram-negative bac-
teria (2,40) enhance serum CSF levels and stim-
ulate myelopoiesis in vivo. In a previous report
(28), we showed that LPS-induced production of
CSF by macrophages is regulated by the con-
comitant production of E prostaglandins. In the
present study, we have investigated the effect of
LPS on CSF-induced cloning of macrophage
precursor cells (39). Our findings show that LPS
can exert different effects, depending upon the
concentration of CSF present in the cultures. In
the presence of optimal to supraoptimal concen-
trations of CSF, LPS inhibited macrophage col-
ony formation in a noncytotoxic manner. In con-
trast, macrophage colony formation induced by
suboptimal concentrations ofCSF was enhanced
by addition of minute amounts of LPS.
MATERIALS AND METHODS
Animals. Male C3H/HeN mice were obtained from
the National Institutes of Health Division of Research
Resources, Bethesda, Md. C3H/HeJ mice of both
sexes were purchased from Jackson Laboratories, Bar
Harbor, Maine. The animals were used at 6 to 8 weeks
of age.
Reagents. LPS was extracted from Escherichia
coli K-235 by the phenol-water method of McIntire et
al. (25). LPS solutions were prepared fresh for each
experiment by suspending the LPS at 1 mg/ml in
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Ca2+- and Mg2+-free Hanks balanced salt solution
(HBSS; Microbiological Associates, Walkersville, Md).
Indomethacin and polymyxin B sulfate were pur-
chased from Sigma Chemical Co. (St. Louis, Mo.).
Appropriate dilutions of reagents in HBSS were added
to the cultures in a volume of 0.1 ml. Conditioned
medium (LCM) and column-fractionated CSF were
prepared from L cells by a modification of the method
of Waheed and Shadduck (42). Mouse L cells (clone
929; Microbiological Associates) were grown in mini-
mum essential medium (NIH Media Production Unit,
Bethesda, Md.) supplemented with 5% fetal calf serum
(Microbiological Associates) and antibiotics (50 U of
penicillin and 50 jig of streptomycin per ml). Confluent
monolayers of cells were trypsinized to remove the
cells from their flasks. The cells were washed three
times in HBSS and suspended at 3 x 105 to 5 x 105
cells per ml in serum-free medium 199 (NIH Media
Production Unit) containing antibiotics. A total of 50
ml of cell suspension was then added to 75-cm2 tissue
culture flasks and incubated for 7 days at 370C in a 5%
C02-in-air incubator. The supernatant medium was
collected by centrifugation and stored frozen at -20'C.
To prepare concentrated LCM, the medium was
thawed and concentrated approximately 200-fold in an
ultrafiltration cell (Amicon Corp., Lexington, Mass.)
with a PM-30 membrane. The concentrate was then
dialyzed for 3 days against three 1,000-fold changes of
distilled, deionized water containing 100 U of penicillin
and 100 Itg of streptomycin per ml. The water-soluble
portion was separated by centrifugation at 10,000 x g
and dialyzed against RPMI 1640 medium containing
antibiotics. After sterilization by passage through 0.22-
Lm filters (Millipore Corp., Bedford, Mass.), the LCM
was stored frozen at -20'C.
To obtain a CSF-enriched preparation, the LCM
(2 ml) was chromatographed at 4VC on a Sephacryl S-
200 (Pharmacia, Uppsala, Sweden) column (2.5 by 95
cm) using reverse flow at a rate of approximately 12
ml/h. The buffer system used was 50 mM tris(hy-
droxymethyl)aminomethane-hydrochloride (pH 7.5),
containing 0.1 M NaCI, and 3-ml fractions were col-
lected. The majority of the CSF was eluted in a range
correlating with marker proteins having molecular
weights of 100,000 to 150,000. These fractions were
pooled, concentrated to the original volume of LCM
applied to the column, and dialyzed against RPMI
1640 plus antibiotics. The concentrate was then filter
sterilized and stored frozen at -20'C.
Biological assays. CSF activity was determined
in soft agar culture of bone marrow cells as previously
described (28). Units of CSF activity represent the
calculated colony yield in 1.0 ml of sample and were
determined from the linear portion of a dilution series.
Cloning of macrophage precursor cells was meas-
ured in liquid culture by a modification of the method
described by Stewart and Lin (39). Thioglycolate-in-
duced (2 ml intraperitoneally, 3 days prior) peritoneal
cells from C3H/HeN mice were suspended in enriched
McCoy 5A medium (28) at 1 x 103 cells per ml. A 2-ml
amount of this cell suspension was then placed in 35-
mm culture dishes (Falcon Division, Becton Dickinson
& Co., Cockeysville, Md.) along with a source of CSF
with or without other reagents. The plates were then
incubated at 37°C for 14 days in 5% C02-in-air atmos-
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phere. Colonies (proliferative centers of 25 cells or
more) were scored with a dissecting microscope at
x30 magnification. Colonies forming under these con-
ditions were greater than 99% macrophages as judged
by cell morphology, differential staining, and phago-
cytosis of antibody-coated sheep erythrocytes (41).
Direct visual assessment of proliferation and viabil-
ity was made by microscopic observation of cells cul-
tured in eight-chambered slides (Lab-Tek no. 4838;
Lab-Tek Products, Div. Miles Laboratories Inc., Na-
perville, Ill.). Peritoneal exudate cells (4 x 104) in 0.4
ml of McCoy medium were added to each well and
allowed to adhere for 2 h at 37°C. After removal of
nonadherent cells by washing, medium containing di-
lutions of LCM or LPS or both was returned to the
cultures. At timed intervals the chambers were in-
spected with an inverted microscope at x200 magni-
fication for cell numbers and for viability as measured
by trypan blue exclusion (41). Based on randomly
selected samples, both the primary and extended-term
cultures were greater than 98% macrophages as judged
by morphology, differential staining, and phagocytosis
of antibody-coated sheep erythrocytes.
Statistical analyses. Comparisons of individual
means were performed with the Student's t test.
RESULTS
Inhibition of macrophage colony forma-
tion by LPS. Addition of LPS to LCM-stimu-
lated adherent peritoneal exudate cells resulted
in a dose-dependent inhibition of macrophage
colony formation (Fig. 1). This inhibitory effect
was most dramatic at supraoptimal dilutions of
LCM and lessened, with lower doses ofLPS (1.0
to 0.01 ,ug/ml), as the dilution ofLCM increased.
LPS by itself did not cause clone formation in
these cultures.
Absence of detectable cytotoxicity. Cer-
tain preparations of LPS have been shown to be
cytotoxic for macrophages at relatively high con-
r
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FIG. 1. Suppression by LPS of macrophage clone
formation induced by LCM. Adherent peritoneal ex-
udate cells from 2 x 103 total exudate cells were
exposed to dilutions of LCM in the presence or ab-
sence of LPS. Colonies were counted 14 days later,
and values represent the mean colony count of trip-
licate cultures.
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centrations (14). Although the LPS preparation
used in this investigation was chosen because it
was not toxic for macrophages in vitro (<5% kill
after overnight incubation of thioglycolate-in-
duced macrophages with 50 jig of LPS per ml),
it was considered necessary to determine
whether the LPS was inhibiting macrophage
colony formation by killing the responding cells.
A direct microscopic analysis was used to ascer-
tain this point. Exudate cells were cultured in
eight-well chamber slides in the presence of
LCM and LPS. At timed intervals the medium
was removed, and the cultures were observed
for both viability, as measured by trypan blue
exclusion, and for total cell numbers. As shown
in Fig. 2A, the LPS alone did not exert any
observable cytotoxic effect on any culture ob-
served. The values shown in this figure repre-
sent viable cell numbers, which in all cases were
>98%. In these control cultures, to which no
LCM was added, there was an approximate two-
fold increase in cell numbers per field during the
10-day observation period. This increase was not
significantly affected by the presence of up to 10
,Ig of LPS per ml. In control cultures treated
with either a 1:100 (20,000 U of CSF) or 1:800
(2,500 U of CSF) dilution of LCM, a significant
proliferative response was observed (Fig. 2B and
C), which was dramatically apparent by day 10.
In those cultures treated with 1:100 LCM (Fig.
2B), LPS exerted an inhibitory effect which was
significantly different (Pc 0.05) from the control
at day 7. In these cultures little increase in cell
numbers occurred between days 7 and 10 al-
though there was no measurable increase in cell
death. In cultures treated with 1:800 LCM (Fig.
2C), an observable inhibition of proliferation was
not apparent until day 10, and again the popu-
lation remained greater than 98% viable. Based
on these results, the inhibitory effect of LPS on
LCM-induced macrophage precursor division
did not appear to be due to a direct cytotoxic
effect of the LPS. The LPS appeared instead to
exert a CSF-dose-dependent cytostatic effect.
Evidence that the inhibitory effect is as-
sociated with lipid A. Macrophages from the
C3H/HeJ mouse have been shown to be either
unresponsive or poorly responsive to a variety
of effects elicited by LPS and the lipid A portion
ofLPS (11, 33, 41, 44). In this study, the exudate
progenitor cells of this mouse strain also failed
to respond to this inhibitory effect of LPS (Fig.
3A) at concentrations which are clearly inhibi-
tory for the LPS-responsive C3H/HeN cells
(Fig. 3B).
These results suggested that the inhibitory
activity was mediated through lipid A. To test
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FIG. 3. Comparative effects of LPS on LCM-in-
duced cloning of macrophage progenitor cells from
C3H/HeJ (A) and C3H/HeN (B) mice. Values are
colony counts after 14 days of incubation ofadherent
cells from 2 X 103 total thioglycolate-inducedperito-
neal exudate cells and represent means of triplicate
cultures. The CSF activity ofthe undiluted LCM used
was 2 x 106 U/ml.
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FIG. 2. Viable cell numbers per X200 microscope field at timed intervals after addition of LCM with or
without LPS. Values represent means offive randomly selected fields and were greater than 98% viable at all
points as measured by trypan blue exclusion. Symbols for LPS doses are as follows (,ig/ml): 0 (0); 0.01 (A);
1.0 (0); 10.0 (-). LCM at 1:100 and 1:800 are 20,000 and 2,500 U of CSF activity per ml, respectively.
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this possibility, the LPS preparation was pre-
treated with polymyxin B, which neutralizes
LPS effects by forming a stable complex with
the lipid A portion ofthe molecule (33). Addition
of the antibiotic to the LPS blocked its inhibi-
tory activity for the sensitive mouse strain (Ta-
ble 1), providing further evidence that the inhib-
itory activity of LPS is a property of the lipid A
moiety.
Effect of indomethacin on the inhibitory
effect of LPS. Kurland and Moore (19) have
recently shown that E prostaglandins inhibit
CSF-induced cloning of both bone marrow and
peritoneal exudate progenitor cells. Since both
LPS (18, 43, 44) and CSF (38) stimulate E pros-
taglandin production by macrophages, the pos-
sibility that these mediators might influence the
cloning efficiency of progenitor cells in this study
was investigated.
Adherent peritoneal exudate cells were ex-
posed to different dilutions of LCM and LPS in
the presence or absence of indomethacin, a po-
tent inhibitor of the cyclooxygenase pathway
of prostaglandin synthesis. The dose of indo-
methacin used (1 Iug/ml) has been shown to be
sufficient to block LPS-induced synthesis of
prostaglandins by macrophages (28). As re-
ported previously by Hadden et al. (16), addition
of indomethacin to the cultures did have an
enhancing effect on factor-induced colony for-
mation (Fig. 4A). Indomethacin, however, failed
to alter the inhibition of clonal proliferation
effected by the addition of LPS (Fig. 4B). Pros-
taglandins, therefore, do not appear to play a
major role in this inhibitory effect of LPS.
Enhanced cloning of macrophage pro-
genitor cells with LPS and suboptimal con-
centrations of CSF. In several experiments,
such as that shown in Fig. 2B, submicrogram
TABLE 1. Neutralization of the suppressive effect of
LPS on macrophage colony formation
by polymyxin B
LPS PBb No. of coloniesUnits of CSF' ( g/ml) (A9npl)per culturet(~t/m1 tg/1) SEW
2,500 0 0 179±5
2,500 1.0 0 82±3
2,500 0 10.0 164 ± 15
2,500 1.0 10.0 192 ± 31
0 1.0 0 0
0 0 10.0 0
a Units of Sephacryl S-200 column-fractionated L
cell-derived colony-stimulating activity per milliliter.
b Polymyxin B sulfate.
'Colony count 14 days after addition of CSF to 2
x 10' thioglycolate-elicited C3H/HeN peritoneal ex-
udate cells. Values represent means of triplicate cul-
tures ± standard error.
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FIG. 4. Effect of indomethacin (INDO, 1 pg/ml) on
LCM-induced cloning ofmacrophageprogenitor cells
either in the absence (A) or presence (B) of LPS.
Values are colony counts after 14 days of incubation
of adherent cells from 2 x 103 thioglycolate-induced
peritoneal exudate cells and represent means of trip-
licate cultures. The CSF activity of the undiluted
LCM used was 2 x 106 U/ml.
doses of LPS enhanced, rather than inhibited,
macrophage cloning stimulated by suboptimal
doses of LCM. This suggested that under certain
circumstances LPS might enhance the cloning
of macrophage progenitor cells. Since recent
studies have shown that crude CSF preparations
might contain high-molecular-weight enhancers
for CSF-induced cloning in vitro (M. Frolich, D.
W. Golde, and M. J. Cline, J. Supramol. Struct.,
suppl. 3. 1979, abstr. no 648, p. 255), the LCM
was fractionated on a Sephacryl S-200 column
to obtain the CSF-positive fractions free of both
high- and low-molecular-weight contaminants.
Results obtained with column-fractionated CSF
are given in Fig. 5. In a dose-dependent manner,
LPS could either suppress or enhance the clon-
ing response of C3H/HeN macrophage progen-
itor cells, depending on the dose of CSF (Fig.
5A). The inhibitory effect of LPS was expressed
at optimal and supraoptimal concentrations of
CSF, whereas the enhancing effect was most
obvious in the suboptimal to optimal CSF con-
centration range. Again, LPS had no significant
effect on CSF-induced cloning ofC3H/HeJ mac-
rophage progenitors (Fig. 5B).
Results shown in Fig. 6 establish two main
points regarding the enhancing effect of LPS on
CSF-induced progenitor cell cloning. First, the
progenitor cells are exquisitely sensitive to this
INFECT. IMMUN.
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FIG. 5. Comparative effects of LPS on CSF-in-
duced cloning of macrophage progenitor cells from
C3H/HeN (A) and C3H/HeJ (B) mice. The CSFprep-
aration used was thepooled fractions ofCSF activity
obtained after gel filtration ofLCM on Sephacryl S-
200. Values are colony counts after 14 days of incu-
bation of adherent cells from 2 x 103 total thioglyco-
late-induced peritoneal exudate cells and represent
means of triplicate cultures.
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FIG. 6. Enhanced cloning of macrophage precur-
sor cells exposed to LPS and 200 U of column-frac-
tionated L cell CSF per ml. Values represented by
closed circles are means of triplicate cultures ± one
standard error, and values represented by open cir-
cles are similar means obtained from cultures incu-
bated in the presence ofpolymyxin B sulfate (PB) at
10 times the concentration of each LPS dose used.
The shaded area represents the mean ± one standard
deviation of the number of colonies formed in re-
sponse only to 200 U ofCSFper ml.
effect of LPS. In the presence of 200 U of CSF,
as little as 10-7 ,ug of LPS per ml was sufficient
to significantly enhance (P c 0.05) the cloning
response. Second, addition of polymyxin B to
the LPS at concentrations 10 times greater than
each LPS dose was sufficient to totally neutral-
ize the enhancing effect of LPS at LPS doses
_iO1-4 ,g/ml. At LPS doses >1i-4 Ig/ml, poly-
myxin B was able to partially neutralize the
enhancing effect. Polymyxin B at concentrations
ranging from 10-8 to 10 ,ug/ml had no effect on
macrophage cloning stimulated by 200 U ofCSF
(data not shown). The reversal by polymyxin B
(Fig. 6 and Table 1), combined with the failure
of C3H/HeJ cells to respond to LPS (Fig. 5B),
suggested that the enhancing effect of LPS, as
well as the inhibitory effect noted at higher CSF
concentrations, was due to lipid A.
Kinetics of the LPS effects. The preceding
experiments established that LPS can either
enhance or suppress CSF-induced cloning of
macrophage progenitor cells, depending upon
the concentration of CSF added to the cultures.
The following experiments were designed to de-
termine the effect of LPS when added before or
after the addition of CSF.
Addition of LPS either 24 h before or after
CSF had little effect on either the inhibitory or
enhancing effect of LPS on the cloning response
(Table 2). Addition of LPS delayed up to 6 days
after CSF also had no effect on the inhibitory
activity ofLPS in the presence of either 2,500 or
20,000 U of CSF/ml (Table 3). In addition, de-
layed addition of LPS to slide-chamber cultures,
although inhibiting proliferation, did not result
in observable cell death (data not shown), sup-
porting the contention that the inhibitory effect
of LPS is not due to cytotoxicity. These results
indicated that the inhibitory effect of LPS could
be exerted on cells already undergoing a prolif-
erative response to relatively high doses of CSF.
Enhanced cloning elicited by 0.001 ,ig of LPS
per ml was diminished when the LPS was added
after CSF and was virtually gone when the LPS
was added 6 days later (Table 3). The LPS was
apparently influencing progenitor cells in a man-
ner that allowed them to proliferate in response
to suboptimal doses of CSF. Upon prolonged
culture these cells gradually lost the capacity to
respond to this effect of LPS.
DISCUSSION
Both LPS and infection with gram-negative
bacteria have profound effects on myelopoiesis
in vivo. Sublethal doses of LPS increase both
serum CSF levels and numbers of mononuclear
phagocytes and granulocytes (6, 8, 21, 35). LPS
has also been found to increase the numbers of
myeloid stem cells in cell cycle in treated animals
(21). Animals infected with gram-negative bac-
teria, such as Salmonella typhimurium, also
show a rapid increase in serum CSF and a sub-
sequent increase in numbers of mononuclear
phagocytes (2, 40). Additionally, it has been
shown that increases in serum CSF after X-
irradiation are associated with the presence of
gram-negative bacteria in the intestinal tract (7),
whereas conventionalization of antibiotic-pre-
2^C
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TABLE 2. Macrophage colony formation by exudate progenitor cells.exposed to LPS or CSF at 0 or 24 h
Addition to culture at: No. of colonies per culture" at LPS dose (,Ag/ml) of:
Units of CSF"
0 h 24 h 0 1.0 0.01 0.0001
1,000 CSF + LPS -c 233 ± 9 141 ± 15 - -
CSF LPS 233 ± 9 168 ± 14 - -
LPS CSF 264 ± 24 170 ± 8 - -
200 CSF + LPS - 111 ± 8 216 ± 10 248 ± 5 248 ± 10
CSF LPS 111 ± 8 222 ± 9 270 ± 12 254 ± 16
LPS CSF 84±6 186± 14 228±6 244± 15
a Units of Sephacryl S-200 column-fractionated L cell-derived colony-stimulating activity per milliliter.
' Colony count 14 days after addition of CSF to 2 X 103 thioglycolate-elicited C3H/HeN peritoneal exudate
cells. Values represent means of triplicate cultures ± one standard error.
c None.
TABLE 3. Effect of delayed addition ofLPS on
macrophage colony formation by exudate progenitor
cells exposed to LCM or Sephacryl S-200-
fractionated CSF
No. of colonies per culture at day of
Units of LPS dose LPS addition':
CSFa (Ag/ml)
0 3 6
20,000' 0 201 ± 11 -d -
1.0 93± 18 89±3 90±24
2,500' 0 338 ± 9 - -
1.0 170±2 178±5 171±7
200' 0 213±9 - -
0.001 362 ± 20 307 37 232 35
a Units of colony-stimulating activity added per culture.
'Colony count 14 days after addition of CSF to 2 x 10'
thioglycolate-elicited C3H/HeN peritoneal exudate cells. Val-
ues represent means of triplicate cultures ± one standard
error.
'Units of LCM-CSF per milliliter.
d
-, 0 LPS control.
eUnits of Sephacryl S-200 pool CSF.
treated canines resulted in an increase in plasma
CSF and a marked increase in bone marrow
stem cells (22). In all of these cases, it is implied
that either LPS or other bacterial products are
stimulating production of CSF which subse-
quently enhances proliferation of the myeloid
progenitor cells. Results reported in this com-
munication, however, provided evidence that
the effects of LPS on myelopoiesis may not be
mediated solely through production of CSF.
Very small doses ofLPS (10-7 Lg/ml) were found
to significantly enhance cloning of exudate mac-
rophage progenitor cells exposed to suboptimal
concentrations of CSF. This enhancing effect
was most probably not due to production of
additional CSF in the cultures since it has been
our experience that adherent exudate cells do
not produce detectable CSF when challenged
with LPS. The possibility that exposure to CSF
might augment CSF production by LPS-stimu-
lated exudate macrophages, however, has not
been eliminated. This possibility also seems un-
likely since the number of clones forming in
response to the combination of submicrogram
doses of LPS and suboptimal concentrations of
CSF often exceeded that observed with optimal
CSF doses (Fig. 5A). Therefore, the enhancing
effect of LPS may be due to some other action
of LPS rather than to endogenous CSF produc-
tion. In this context, the enhancement may be
related to the observations of Dienstman and
Defendi (9) that a significant portion of the
exudate macrophage population can be directly
stimulated by LPS to enter the cell cycle. Al-
though, as shown in our study, LPS alone is
insufficient to permit a cloning response, it is
possible that in the presence of suboptimal con-
centrations of CSF, LPS provides the necessary
stimulus for these cells to enter the cell cycle
while the CSF provides stimulation for sustained
proliferation.
LPS in the presence of optimal or supraopti-
mal concentrations of CSF was found to sup-
press cloning of macrophage progenitor cells.
This inhibition is not the result of a cytotoxic
effect of the LPS. As with the enhancing effect
of LPS, it is unclear whether this inhibition is
due to a direct action of LPS on the progenitor
cell or is mediated by some LPS-induced mac-
rophage product. Three major factors which
should be considered as possible inhibitors are
E prostaglandins (19), tumor necrosis factor (36),
and interferon (17). Addition of indomethacin,
which is sufficient to inhibit prostaglandin pro-
duction (28), failed to alter the inhibitory effect
of LPS (Fig. 2). This indicated that prostaglan-
dins, which can inhibit CSF-induced mono-
poiesis in vitro (19), were not responsible for the
inhibitory effect of LPS in these experiments.
Recently, Shah et al. (36) presented evidence
suggesting that tumor necrosis factor can inhibit
CSF-induced myelopoiesis in vitro. In a recent
report from this laboratory (24), we presented
evidence that CSF-cloned macrophages chal-
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lenged with LPS produce a cytotoxic factor with
properties similar to serum-derived tumor ne-
crosis factor. Addition of partially purified serum
tumor necrosis factor (24) to the cultures, how-
ever, had no effect on the CSF-induced cloning
response (data not shown). This indicated that
the inhibitory effect ofLPS in these experiments
was probably not due to the production of tumor
necrosis factor in the cultures. Interferon has
been shown to have anti-proliferative activities
for mammalian cells (15) and has been suggested
to inhibit CSF-induced myelopoiesis in vitro
(17). LPS is known to induce interferon produc-
tion by macrophages (23), and we have recently
reported that CSF-treated exudate macrophages
produce enhanced levels of interferon when
challenged with LPS (29). In preliminary exper-
iments, addition to the cultures of antiserum
prepared against murine type 1 interferon (Na-
tional Institute of Allergy and Infectious Dis-
eases, Antiviral Substances Program) partially
neutralized the inhibitory effect of LPS without
affecting the normal cloning response to CSF.
Although more extensive investigation of the
possible role ofinterferon in this inhibitory effect
of LPS is required, it is clear that the effects of
LPS, either inhibitory or enhancing, are related
to the dose ofCSF to which the cells are exposed.
With respect to interferon, it is important to
note that a relationship does appear to exist
between the effect of CSF as a macrophage-
stimulating agent and the results obtained in the
present study. Exudate macrophages treated
with at least 1,000 U of CSF display a signifi-
cantly enhanced responsiveness to LPS as meas-
ured by interferon production (29). Doses of
CSF less than 1,000 units yielded less than sig-
nificant enhancement (29). Viewed in this con-
text, it is possible that in the presence of higher
concentrations of CSF the exudate population
responds to LPS in an activating fashion which
precludes or inhibits proliferation, whereas LPS
promotes a proliferative response in cultures
exposed to suboptimal concentrations of CSF.
Regardless of the mechanism by which LPS
either enhances or inhibits CSF-induced cloning
of macrophage precursor cells, results obtained
in this study indicate that lipid A is probably the
active portion of the LPS molecule in these
effects. LPS neither enhanced nor inhibited the
cloning response of progenitor cells from the
C3H/HeJ mouse strain whose macrophages are
genetically deficient in response to lipid A (11,
33, 41, 44). Also, both the enhancing and inhib-
itory effects of LPS on cells from genetically
responsive mice could be either totally or par-
tially neutralized by polymyxin B, an antibiotic
which binds to lipid A (31).
Although many questions remain to be re-
solved regarding the alterations of in vitro mon-
opoiesis by LPS, these results serve to reem-
phasize the relationship between the mononu-
clear phagocyte system and LPS in both the
infected and healthy host. They clearly suggest
that LPS is intimately involved in regulation of
monopoiesis, both indirectly through stimula-
tion of CSF production and by its effects on the
CSF-responsive progenitor cells.
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